Pressure BioSciences Inc. PBIO Archives - Page 13 of 22

ThursdayAug 22, 2019 12:19 pm

QualityStocksNewsBreaks – Pressure BioSciences Inc. (PBIO) Receives Two New Purchase Orders for Revolutionary BaroShear K45 Processing System

Pressure BioSciences Inc. (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based technology and products to the worldwide life sciences and other industries, today announced its receipt of two additional purchase orders for its revolutionary BaroShear(TM) K45 processing system. According to the update, the BaroShear K45, based on the company’s proprietary Ultra Shear Technology(TM) (“UST”) platform, is a unique and powerful nanoemulsification system designed to resolve one of the CBD industry’s most critical problems: the extremely poor solubility of CBD Oil in water. “We fully appreciate both the challenges and the significant emerging market opportunity of…

ThursdayAug 15, 2019 11:54 am

QualityStocksNewsBreaks – Pressure BioSciences Inc. (PBIO) Releases Q2 2019 Financial Results, Provides Business Update

Pressure BioSciences (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based technology and products to the worldwide life sciences and other industries, today announced financial results for the second quarter ended June 30, 2019, provided a business update, and offered guidance for the remainder of the fiscal year and for FY 2020. In the update, the company reported 2019 second quarter highlights that include record consumables sales, strong growth in BaroFold and UST Services, and launch of a revolutionary CBD processing system. “Because of the poor water solubility of today’s oil-based CBD products, most ingested CBD…

WednesdayAug 14, 2019 10:05 am

QualityStocksNewsBreaks – Pressure BioSciences Inc. (PBIO) to Host Teleconference to Discuss Q2 2019 Financial Results and Provide Business Update

Pressure BioSciences (OTCQB: PBIO) (“PBI”), a leader in the development and sale of broadly enabling, pressure-based technology and products to the worldwide life sciences and other industries, on Tuesday announced that it will host a teleconference to discuss its second quarter 2019 financial results and to provide a business update. The teleconference is scheduled for 4:30 PM ET on Thursday, August 15, 2019, and will include a company presentation followed by a question and answer period. Interested parties may listen to the teleconference live by dialing (844) 602-0380 (North America); (862) 298-0970 (International) and entering the following verbal passcode for…

TuesdayAug 13, 2019 11:22 am

Pressure BioSciences Inc. (PBIO) Enters Contract Services Agreement with World-Renowned Biotherapeutics Firm

PBIO expects to achieve a significant revenue increase in 2019 and beyond through the expansion of its proprietary BaroFold platform into the estimated $44 billion global bioprocess technology market Over 200 therapeutic proteins and peptides are currently approved by the FDA for use with conditions such as cancer, immunological and metabolic disorders and infectious diseases Hundreds of additional protein and peptide-based drugs are in development worldwide PBIO’s proprietary BaroFold platform offers a unique and cost-effective way to address two of the most complex and challenging issues critical to the development and manufacture of therapeutic proteins Pressure BioSciences Inc. (OTCQB: PBIO),…

MondayAug 05, 2019 3:12 pm

QualityStocksNewsBreaks – Pressure BioSciences Inc. (PBIO) Solves CBD Water-Solubility Problem with Patented UST Platform

Pressure BioSciences (OTCQB: PBIO) recently launched its BaroShear K45 system which is based on the company’s proprietary Ultra Shear Technology (“UST”) platform. The innovative system has been optimized for the unique purpose of producing high quality, water-soluble nanoemulsions of CBD oil in water (http://ibn.fm/MY4mE). An article further discussing the company reads, “CBD, a non-psychoactive compound believed to offer powerful health benefits, is extracted from the cannabis plant in an oil. After ingestion, because oils are not well absorbed, most of the CBD is flushed from the body, leaving little of the product to provide its beneficial properties. Because of these solubility…

FridayAug 02, 2019 2:17 pm

QualityStocksNewsBreaks – Pressure BioSciences Inc. (PBIO) Provides Proprietary Benchtop UST Instrument to Ohio State Scientists

Pressure BioSciences (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based technology and products to the worldwide life sciences and other industries, recently provided a working benchtop Ultra Shear Technology (“UST”) instrument to scientists at The Ohio State University. An article further discussing the company reads, “Dr. Edmund Y. Ting, senior vice president of engineering at PBI, sees the company’s collaborative research in this space with Ohio State University as a game changer for the food-science industry. PBIO recently delivered a working benchtop UST instrument to Ohio State scientists who are studying pressure and shear effects…

TuesdayJul 30, 2019 11:18 am

Pressure BioSciences Inc.’s (PBIO) Entry into CBD Market Aims Next-Gen Nanoemulsification Platform at Critical Water-Solubility Issues

PBIO’s proprietary Ultra Shear Technology (UST) platform achieves the long sought-after ability to create truly water-soluble CBD oil that can provide optimized bioavailability CBD sales are projected to reach $89 billion by 2024 with a CAGR of 37 percent (2018-2024 forecast period) Analysts predict that the biggest short-term challenge for CBD businesses will be oversaturation and stiff competition in the marketplace; companies producing the highest-quality, most bioavailable CBD products are expected to earn top customer loyalty Finding success in the lucrative yet ultra-competitive CBD industry is a daunting challenge for businesses in the space, with oversaturation in the marketplace being…

ThursdayJul 25, 2019 12:11 pm

QualityStocksNewsBreaks – Pressure BioSciences Inc. (PBIO) Announces First Sale of the BaroShear K45, A Revolutionary Water-Soluble CBD Manufacturing System

Pressure BioSciences (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based technology and products to the worldwide life sciences and other industries, today announced the initial sale of its revolutionary BaroShear(TM) K45 processing system. According to the update, the novel instrument system is based on the company’s proprietary Ultra Shear Technology(TM) (“UST”) platform and is designed to resolve one of the most critical problems facing CBD manufacturers today: the extremely poor water solubility of CBD Oil. “We are thrilled to be the first purchaser of the BaroShear K45 system,” Nano CBD Cosmetics LLC Founder Christopher Holden…

WednesdayJul 24, 2019 12:19 pm

QualityStocksNewsBreaks – Pressure BioSciences Inc. (PBIO) Announces Second Major Contract Utilizing its BaroFold Technology Platform

Pressure BioSciences (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based technology and products to the worldwide life sciences and other industries, today announced its entry into a contract services agreement with a multi-billion biotherapeutics company to enhance the manufacturing process of one of their candidate protein drugs. Per the update, the manufacturing of therapeutic proteins can be a complex and challenging process, and PBI’s BaroFold(TM) technology platform offers a unique and cost-effective way to address major challenges. “The BaroFold platform can be applied to the development and production of many different therapeutic proteins, can improve…

ThursdayJul 18, 2019 11:48 am

QualityStocksNewsBreaks – Pressure BioSciences Inc.’s (PBIO) Flagship Barocycler 2320EXTREME Featured at International Conference in China

Pressure BioSciences (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based technology and products to the worldwide life sciences and other industries, this morning announced that its flagship Barocycler 2320EXTREME was prominently featured at a three-day, internationally-attended scientific conference held at the elite Westlake University in Hangzhou, China. Professor Tiannan Guo, MD., PhD, a well-known protein research scientist, was one of the primary conference organizers. Professor Guo’s Westlake laboratory was named a PBI Center of Excellence in 2017. “Many of the studies on cancer biopsy tissues performed at Westlake and in the laboratories of our collaboration…

Site Search

Company Search

Tag: Pressure BioSciences Inc. PBIO